Trial Profile
A randomized, double-blind, multicenter, placebo-controlled study to determine the efficacy and safety of BTDS [buprenorphine transdermal system; Norspan] compared to placebo in subjects with moderate to severe low back pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 28 Oct 2017
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Back pain
- Focus Therapeutic Use
- Sponsors Mundipharma International
- 25 Nov 2006 New trial record.